H&K AG

MLHK

Equity

ISIN DE000A11Q133 / Valor 24304910

Euronext - Euronext Paris (2026-10-09)

EUR 34.30+5.86%

H&K AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

H&K AG is a multinational pharmaceutical company with a long-established history that has evolved from a small, family‐owned enterprise into an organization integrating research, development, manufacturing, and marketing. The firm operates through regional hubs, including key centers in Asia, where it manages strategic clinical research activities and oversees commercial operations across several territories. Over the years, H&K AG has broadened its therapeutic pipeline by incorporating specialized biotech ventures and leveraging strategic acquisitions that have enhanced its capabilities in areas such as oncology and other core treatment fields. This integrated approach enables the company to advance drug candidates from discovery through clinical development, reflecting a balanced focus on innovation and global operational efficiency.

Summarized from source with an LLMView SourceSector: Industrials

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-27.3%1Y

-65.5%3Y

-49.6%5Y

Performance

64.1%1Y

70.3%3Y

89.4%5Y

Volatility